Replies to post #58420 on Progressive Care Inc (RXMD)

[Wangenstein]

Are you honestly basing your analysis on the idea that March 2016's revenue was exactly $1,500,000 and that March 2017's revenue was exactly $1,600,000?

GARBAGE IN, GARBAGE OUT

[gedi8]

Are you kidding. Your March 2016 and March 2017 Revenue figures are incorrect. Your post is once again an example of how your facts lie. Watch for the April revenues...

Oh, and by the way what happened to your doomsday prediction that was supposed to occur last Friday after the close. Guess you were wrong about that too.

[DCorleone]

Projection on % in your Formula was on a Yearly Projection, and cannot be used as a basis for your Conclusions. Three month Sample of Actual Numbers, shows RXMD Revenue Projection ahead of schedule, but making any DETERMINATION, GOOD or BAD, to stay Consistent of how close RXMD REVENUE will come to CEO's Projections can be made at end of year. One Month sample considering there are 3 months of Actual Numbers, any sophisticated Investor will see it as an attempt at skewing the ACTUAL Results. BJMO

Closer to 18%

Three Months Ended

March 31, 2017
Sales - net $ 4,700,000

March 31, 2016
Sales - net $ 3,949,385

March 31, 2015
Sales - net $ 3,116,028

[Wangenstein]

Yet again, a reminder: seasonality exists.

It's the reason that, for years now, RXMD's revenue for Q1 < Q2 < Q3 < Q4.

Taking a monthly average for the last six months of the year and comparing it to an average of the first three months of the next year does not work as a reasonable comparison or expectation.

GARBAGE IN, GARBAGE OUT

[Jimmy Quick]

What-En-Blazes - Sensibility in Projections is Falling Fast


First of all, who cares if it is 6.7% or 10%, not worth the time to debate, we only have rounded numbers, so impossible to determine actual.

SCRIPT COUNT IN MARCH WAS ACTUALLY MORE, AGAIN, but this was already known, because I know you have this calculation, and still a choice was made in this post to present in a way that made it look less.

March 2016 18,600/28 working days = 664.3
March 2017 18,500/27 working days = 685.2

So increase in scripts per working day was 20.9 x 27 working days = 564 scripts increase in March 2017 over March 2016, and that isn’t even considering the transition from 30 day scripts to 90 day scripts that took place in the last year. Which makes us look even better!!!

Quote: THE SCRIPT COUNT WAS LESS AND THE COSTS WERE MORE – It was the script price that increased 6.7%. If the Script prices remained the same this March Revenue would have been less.

You know this how?

Taking this bulletproof, LOL, analysis to every month in 2017. So now the Revenue percentage increase for the month of March is being used to determine how much PharmCo increased the price of scripts to get an increase in revenue to make them look better. So since PharmCo had a 6.7% increase in revenue for March, this was just the result of increases in the prices charged to their consumers. Well if that is true, then I guess the company increased the price of scripts for January by 23% and thought what the heck let’s increase prices by 36% for February, and then thought, man we are looking too good on revenue, so let’s increase our prices by only 6.7% for March. This is just a laughable analysis and conclusion.

The rest of the calculations have been proven inaccurate, so not addressing AGAIN.

[Spider Web]

TOO EXPENSIVE

WHY WOULD ANYONE WANT TO
BUY THIS BETWEEN 0.015 & 0.02

WHEN IT CAN BE BOUGHT AT 0.005
WITH A LOT LESS DOWNSIDE RISK